Evidence map›Paper›PMID 33998629›Full record

ArticleJournal of materials chemistry. B2021

Spatially heterogeneous epidermal growth factor release from microporous annealed particle (MAP) hydrogel for improved wound closure.

Lauren Pruett, Regan Ellis, Meghan McDermott, Colleen Roosa, Donald Griffin

Open access · bronzeAbstract read
In one paragraph

Article in Journal of materials chemistry. B, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Granular Hydrogels for Harnessing the Immune Response.Advanced healthcare materials · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lauren PruettDepartment of Biomedical Engineering, 415 Lane Road, Charlottesville, VA, 22903, USA. drgriffin@virginia.edu.ORCID 0000-0002-2121-1013
Regan EllisDepartment of Biomedical Engineering, 415 Lane Road, Charlottesville, VA, 22903, USA. drgriffin@virginia.edu.
Meghan McDermottDepartment of Biomedical Engineering, 415 Lane Road, Charlottesville, VA, 22903, USA. drgriffin@virginia.edu.
Colleen RoosaDepartment of Biomedical Engineering, 415 Lane Road, Charlottesville, VA, 22903, USA. drgriffin@virginia.edu.
Donald GriffinDepartment of Biomedical Engineering, 415 Lane Road, Charlottesville, VA, 22903, USA. drgriffin@virginia.edu.ORCID 0000-0002-3458-867X
Charlottesville Medical Research · US

Funding

Engineering Injectable Microporous Hydrogels for Diabetic Wound RepairR01DK126020 · NIDDK · UNIVERSITY OF VIRGINIA · PI GRIFFIN, DONALD RICHIERI · 2021 to 2025
$3.1M
Engineering Injectable Microporous Hydrogels for Diabetic Wound RepairR56DK126020 · NIDDK · UNIVERSITY OF VIRGINIA · PI GRIFFIN, DONALD RICHIERI · 2020 to 2020
$147k
Improving Spontaneous Gradient Formation in Hydrogels Using Agent-Based ModelingF31HL154731 · NHLBI · UNIVERSITY OF VIRGINIA · PI PRUETT, LAUREN · 2020 to 2021
$73k
NHLBI NIH HHS F31 HL154731NIDDK NIH HHS R01 DK126020NIDDK NIH HHS R56 DK126020
6 · The paper itself

Abstract

Microporous annealed particle (MAP) hydrogel has been a promising scaffold platform technology to promote immediate tissue integration in injured tissue environments. The addition of growth factors has the potential to accelerate tissue integration and enhance scaffold-mediated healing. Growth factor releasing scaffolds face the translational hurdle of limited solubilized protein shelf stability; however, to address this hurdle we present a lyophilized MAP scaffold which can be effectively rehydrated directly prior to use. Our new approach includes a heterogenous MAP scaffold wherein 5% of the microgels contain immobilized heparin loaded with epidermal growth factor (EGF) at 1 μg mL

Indexed as

Biocompatible MaterialsCell LineCell MovementEpidermal Growth FactorFibroblastsHumansHydrogelsMaterials TestingParticle SizePorositySurface PropertiesWound HealingBiocompatible MaterialsEpidermal Growth FactorHydrogels

Identifiers

PMID33998629
PMCPMC8446298
OpenAlexW3161736487

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.